A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

MED Michigan Holdings Acquires Surge Cardiovascular and 3T Medical Assets

MED Michigan Holdings, LLC, a newly formed entity affiliated with MED Alliance Solutions, has completed the acquisition of medical device manufacturer Surge Cardiovascular and certain assets of medical device distributor 3T Medical Systems.

Surge Cardiovascular will continue its focus and expertise of manufacturing cardiovascular surgery products while operations will be managed by MED Michigan Holdings. MED Alliance Solutions has been the exclusive clinical specialty distributor of Surge Cardiovascular products since 2012 and became the sole distributor of the acquired 3T Medical assets in March 2020.

“The MED Michigan Holdings investment secures the MED Alliance Solutions supply chain and allows brand expansion of its cardiac surgery device portfolio,” said Mike Schroeder, president of MED Michigan Holdings and MED Alliance Solutions. “Customers will continue to experience the same level of uninterrupted quality products and excellent service.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy